ATR and B-cell chronic lymphocytic leukemia: However, one feature that might limit its potential utility as a single agent is its functional dependence upon cell proliferation, with quiescent CLL cells being relatively resistant to ATR inhibitors due to the downregulation of ATR in noncycling cells [68,136].